Captrust Financial Advisors Karuna Therapeutics, Inc. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $6,751 - $8,941	41 Added 2.71%	1,555 $262,000
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $266,948 - $363,693	1,514 New	1,514 $328,000
Q2 2022 Aug 23, 2022	SELL	$93.97 - $143.33 $281 - $429	-3 Reduced 3.53%	82 $10,000
Q2 2022 Aug 16, 2022	BUY	$93.97 - $143.33 $7,047 - $10,749	75 Added 750.0%	85 $11,000
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $98 - $132	1 Added 11.11%	10 $1,000

Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $110 - $159	1 Added 12.5%	9 $1,000
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $322 - $407	3 Added 60.0%	8 $1,000
Q1 2021 May 17, 2021	BUY	$95.46 - $133.08 $477 - $665	5 New	5 $1,000

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.